Cover Image
市場調查報告書

尋常性魚鱗癬:全球臨床實驗檢討

Ichthyosis Vulgaris Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 296022
出版日期 內容資訊 英文 55 Pages
訂單完成後即時交付
價格
Back to Top
尋常性魚鱗癬:全球臨床實驗檢討 Ichthyosis Vulgaris Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月10日 內容資訊: 英文 55 Pages
簡介

本報告提供尋常性魚鱗癬治療藥的相關臨床實驗資料,彙整臨床實驗數及被實驗人數,各階段及各方面狀況,有潛力的企業,開發中的治療藥等資訊,為您概述為以下內容。

簡介

各地區的臨床實驗趨勢

  • 各國臨床實驗趨勢
    • 歐洲的主要5個國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗

G7各國的臨床實驗:各臨床實驗狀況

各方面的臨床實驗情形

現在進行中的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 尋常性魚鱗癬治療藥參與臨床實驗的主要企業

潛力治療藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • ORFAGEN
    • Laboratoires Pierre Fabre SA
    • GlaxoSmithKline plc
    • Galderma S.A.
  • 主要大學/實驗室/醫院臨床實驗概要
    • FDA Office of Orphan Products Development
    • National Human Genome Research Institute
    • The National Institute of Allergy and Infectious Diseases
    • Uppsala University
    • Northwestern University
    • Hopital Necker-Enfants Malades
    • National Cancer Institute
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases

附錄

圖表

目錄
Product Code: GDHC1965CTIDB

GlobalData's clinical trial report, "Ichthyosis Vulgaris Global Clinical Trials Review, H1, 2014" provides data on the Ichthyosis Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ichthyosis Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ichthyosis Vulgaris. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ichthyosis Vulgaris
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ichthyosis Vulgaris to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ichthyosis Vulgaris Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • ORFAGEN
      • Clinical Trial Overview of ORFAGEN
      • Laboratoires Pierre Fabre SA
      • Clinical Trial Overview of Laboratoires Pierre Fabre SA
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Galderma S.A.
      • Clinical Trial Overview of Galderma S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • FDA Office of Orphan Products Development
      • Clinical Trial Overview of FDA Office of Orphan Products Development
      • National Human Genome Research Institute
      • Clinical Trial Overview of National Human Genome Research Institute
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Uppsala University
      • Clinical Trial Overview of Uppsala University
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Hopital Necker-Enfants Malades
      • Clinical Trial Overview of Hopital Necker-Enfants Malades
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Ichthyosis Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by ORFAGEN, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by National Human Genome Research Institute, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital Necker-Enfants Malades, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014*

List of Figures

  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Ichthyosis Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top